Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methotrexate (MTX) sensitivity of childhood B-precursor acute lymphoblastic leukemia (BP-ALL).

被引：0
|
作者：
Taub, JW
Kaspers, GJL
Rots, MG
Van Zantwijk, CH
Matherly, LH
Ravindranath, Y
机构：
[1] Childrens Hosp Michigan, Detroit, MI 48201 USA
[2] Karmanos Canc Inst, Detroit, MI USA
[3] Wayne State Univ, Sch Med, Detroit, MI USA
[4] Vrije Univ Amsterdam, Univ Hosp, Amsterdam, Netherlands
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
428
引用
收藏
页码：100A / 100A
页数：1
相关论文
共 50 条
  • [1] Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methotrexate (MTX) sensitivity of childhood B-precursor acute lymphoblastic leukemia (BP-ALL).
    Ravindranath, Y
    Kaspers, GJL
    Rots, MG
    Van Zantwijk, CH
    Taub, JW
    Matherly, LH
    LEUKEMIA, 2001, 15 (03) : 496 - 496
  • [2] Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia
    JW Taub
    LH Matherly
    Y Ravindranath
    G-J L Kaspers
    MG Rots
    CH Zantwijk
    Leukemia, 2002, 16 : 764 - 765
  • [3] Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia
    Taub, JW
    Matherly, LH
    Ravindranath, Y
    Kaspers, GJL
    Rots, MG
    van Zantwijk, CH
    LEUKEMIA, 2002, 16 (04) : 764 - 765
  • [4] The clinical significance of methylenetetrahydrofolate reductase (MTHFR) polymorphisms in acute lymphoblastic leukemia
    Hanaa H. Arnaout
    Mervat M. Khorshied
    Iman A. Shaheen
    Heba M. Gouda
    Noha Y. Ibrahim
    Naglaa F. Koura
    Comparative Clinical Pathology, 2012, 21 (1) : 39 - 47
  • [5] Leukemic clonogenic cells in childhood hyperdiploid B-cell precursor acute lymphoblastic leukemia (BP-ALL).
    Gussetis, ES
    Peristeri, J
    KitraRoussou, V
    Mikraki, V
    Graphakos, S
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 467 - 467
  • [6] MTHFR POLYMORPHISMS ARE ASSOCIATED WITH MTX TOXICITY AND OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Indolfi, Paolo
    D'Angelo, Velia
    Francese, Matteo
    Iannotta, Adriana
    Pecoraro, Giulia
    Ramaglia, Maria
    Fusco, Claudia
    Pota, Elvira
    Di Pinto, Daniela
    Oreste, Matilde
    Indolfi, Cristiana
    Casale, Fiorina
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 726 - 726
  • [7] MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
    Umerez, Maitane
    Gutierrez-Camino, Angela
    Munoz-Maldonado, Carmen
    Martin-Guerrero, Idoia
    Garcia-Orad, Africa
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 69 - 78
  • [8] THE INFLUENCE OF METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) POLYMORPHISMS ON THE SEVERITY OF MEDIUM DOSE-METHOTREXATE INFUSION RELATED TOXICITY AND PROGNOSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Karakukcu, M.
    Unal, E.
    Mutlu, F.
    Ozdemir, M.
    Patiroglu, T.
    Ozkul, Y.
    HAEMATOLOGICA, 2012, 97 : 489 - 489
  • [9] 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children
    Alcasabas, Patricia
    Ravindranath, Yaddanapudi
    Goyette, Gerard
    Haller, Andrew
    del Rosario, Luz
    Lesaca-Medina, Maria Ysabel
    Darga, Linda
    Ostrea, Enrique M., Jr.
    Taub, Jeffrey W.
    Everson, Richard B.
    PEDIATRIC BLOOD & CANCER, 2008, 51 (02) : 178 - 182
  • [10] Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis
    Yang, Lin
    Hu, Xin
    Xu, Luhang
    TUMOR BIOLOGY, 2012, 33 (05) : 1445 - 1454
12345